Green Planet Bioengineering Co Ltd
GPLB · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.23 | 1.46 | 7.46 | -2.11 |
| FCF Yield | -0.82% | -0.75% | -0.07% | -0.10% |
| EV / EBITDA | 0.00 | -310.07 | -1,491.71 | -192.69 |
| Quality | ||||
| ROIC | 0.00% | 117.29% | 126.08% | 2.75% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.76 | 1.47 | 1.01 | 0.88 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -8.94% | 12.80% | 38.76% | -108.13% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | -115.12 | 0.00 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |